Natus Medical (BABY) Tops Q1 EPS by 4c

Natus Medical (NASDAQ: BABY) reported Q1 EPS of $0.34, $0.04 better than the analyst estimate of $0.30. Revenue for the quarter came in at $87.3 million versus the consensus estimate of $90.47 million.

GUIDANCE:

Natus Medical sees Q2 2016 EPS of $0.35-$0.36, versus the consensus of $0.37. Natus Medical sees Q2 2016 revenue of $92.0-93.0 million, versus the consensus of $93.9 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Ocean Power Technologies revises fiscal 2026 results after audit